CD105 (Endoglin) as negative prognostic factor in AML

While several genetic and morphological markers are established and serve to guide therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional markers to better stratify patients. CD105 (Endoglin) is a type I transmembrane protein reported to induce activation and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kauer, Joseph, Schwartz, Karolin, Tandler, Claudia, Hinterleitner, Clemens, Roerden, Malte, Jung, Gundram, Salih, Helmut R., Heitmann, Jonas S., Märklin, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892812/
https://www.ncbi.nlm.nih.gov/pubmed/31797971
http://dx.doi.org/10.1038/s41598-019-54767-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892812/
https://www.ncbi.nlm.nih.gov/pubmed/31797971
http://dx.doi.org/10.1038/s41598-019-54767-x

Ejemplares similares